Efficacy and Safety of Tenofovir Plus Lamivudine Plus Efavirenz Regimen as First-line Antiretroviral Therapy

NCT01844297 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

500

Enrollment

OTHER

Sponsor class

Conditions

AIDS/HIV PROBLEM

Interventions

DRUG: TDF+3TC+EFV

Sponsor

Peking Union Medical College